Literature DB >> 915271

Mediation of CRP-dependent phagocytosis through mouse macrophage Fc-receptors.

R F Mortensen, J A Duszkiewicz.   

Abstract

The purified acute phase serum constituent, C-reactive protein (CRP), was examined for its ability to interact with mouse macrophage Fc-receptors when serving as an opsonin for C-polysaccharide (CPS)-coated erythrocytes (E.CPS). The ingestion of E.CPS-CRP by macrophage monolayers was dependent on the presence of CRP on the erythrocyte surface and on the treatment of the CRP-sensitized cells with human complement (C). The ingestion of E.CPS-CRP-C was inhibited by exposing the macrophages to either 2-deoxyglucose, a selective inhibitor of Fc-receptor activity, or to aggregated gamma-globulin. Inhibition was also brought about by plating macrophages on glass-bound immune complexes of BSA/anti-BSA (IgG) but not on complexes formed with the F(ab')2 fragment of the anti-BSA. Substrate-bound complexes of CPS-CRP selectively inhibited the uptake of IgG-coated E, EA(IgG); the inhibition was proportional to the concentration of CRP used to form the complex. The opsonin-independent ingestion of latex particles was not altered by these Fc-receptor blocking procedures. These findings coupled with the recent demonstration of a sequence homology between CRP and the CH3 domain of human IgG lead us to propose shared opsonic functions for antibody and CRP.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915271

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Molecular genetics, structure, and function of C-reactive protein.

Authors:  J M Kilpatrick; J E Volanakis
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  A comparison of the acute-phase response in middle aged and elderly patients.

Authors:  J Woo; M Arumanayagam; D MacDonald; K S Woo
Journal:  Postgrad Med J       Date:  1989-01       Impact factor: 2.401

Review 4.  C-reactive protein, inflammation, and innate immunity.

Authors:  R F Mortensen
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 5.  Mechanisms of macrophage activation.

Authors:  H M Ogmundsdóttir; D M Weir
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

Review 6.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

Review 7.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

8.  The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection.

Authors:  S Nakayama; H Gewurz; T Holzer; T W Du Clos; C Mold
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

9.  Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models.

Authors:  B P Barna; D A Eppstein; M J Thomassen; J J Nestor; T Ho; S V Medendorp; S D Deodhar
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

10.  Lesional modulation of peripheral monocyte leucotactic responsiveness in leprosy.

Authors:  P B Campbell; T A Tolson; L Yoder; J Loesch; J L Krahenbuhl
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.